As of 2025-05-15, the Intrinsic Value of SMS Pharmaceuticals Ltd (SMSPHARMA.NS) is 105.56 INR. This SMSPHARMA.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 259.23 INR, the upside of SMS Pharmaceuticals Ltd is -59.30%.
The range of the Intrinsic Value is 73.18 - 170.83 INR
Based on its market price of 259.23 INR and our intrinsic valuation, SMS Pharmaceuticals Ltd (SMSPHARMA.NS) is overvalued by 59.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 73.18 - 170.83 | 105.56 | -59.3% |
| DCF (Growth 10y) | 89.86 - 191.26 | 124.02 | -52.2% |
| DCF (EBITDA 5y) | 178.34 - 241.49 | 203.13 | -21.6% |
| DCF (EBITDA 10y) | 155.11 - 240.77 | 189.75 | -26.8% |
| Fair Value | 186.40 - 186.40 | 186.40 | -28.09% |
| P/E | 139.52 - 199.51 | 160.52 | -38.1% |
| EV/EBITDA | 126.47 - 232.89 | 157.47 | -39.3% |
| EPV | (5.22) - 5.12 | (0.05) | -100.0% |
| DDM - Stable | 36.45 - 92.00 | 64.22 | -75.2% |
| DDM - Multi | 63.33 - 129.07 | 85.45 | -67.0% |
| Market Cap (mil) | 22,980.74 |
| Beta | 1.63 |
| Outstanding shares (mil) | 88.65 |
| Enterprise Value (mil) | 25,745.17 |
| Market risk premium | 8.31% |
| Cost of Equity | 14.81% |
| Cost of Debt | 7.27% |
| WACC | 13.68% |